Letter: the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy - authors' reply
Aliment Pharmacol Ther
.
2017 Oct;46(7):703-704.
doi: 10.1111/apt.14259.
Authors
M M Mücke
1
,
V T Mücke
1
,
J Vermehren
1
Affiliation
1
Medizinische Klinik 1, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany.
PMID:
28880448
DOI:
10.1111/apt.14259
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents
Hepatitis B Surface Antigens*
Hepatitis B virus*
Humans
Virus Activation / drug effects
Substances
Antiviral Agents
Hepatitis B Surface Antigens